Free Trial
OTCMKTS:GENN

Genesis Healthcare (GENN) Stock Price, News & Analysis

Genesis Healthcare logo
$0.0003 +0.00 (+50.00%)
As of 06/26/2025 10:53 AM Eastern

About Genesis Healthcare Stock (OTCMKTS:GENN)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.00
$0.30
Volume
59,371 shs
Average Volume
8,012 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

Receive GENN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

GENN Stock News Headlines

GENN Genesis Healthcare, Inc.
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Genesis Research Group Unveils Enhanced US Market Access Data Analytics
New REIT Gained 20% In the Last Three Weeks: Should You Buy it?
See More Headlines

GENN Stock Analysis - Frequently Asked Questions

Genesis Healthcare's stock was trading at $0.0002 on January 1st, 2025. Since then, GENN stock has increased by 50.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of GENN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Genesis Healthcare (GEN), QUALCOMM (QCOM), Zura Bio (ZURA), Aurora Cannabis (ACB), BlackBerry (BB), CymaBay Therapeutics (CBAY) and Canopy Growth (CGC).

Company Calendar

Today
6/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - NURSING HMS
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:GENN
Employees
47,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-2.56
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:GENN) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners